MR-guided radiotherapy for rectal cancer

Author(s): Dr Manasi Ingle, Dr Shreerang Bhide

Hospital: The Institute of Cancer Research

Reference: RAD Magazine, 47, 555, 17-18


Colorectal cancer is the third most common cancer in the UK, with rectal cancer accounting for approximately 20-30% of all cases and men being affected more than women. Treatment of rectal cancer is not only to prevent disseminated disease, but to reduce the risk of local recurrence (LR). Unfortunately LR causes significant morbidity and distress […]

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more